Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by 68gallium Dotatate

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00001160Recruiting

Studies on Tumors of the Thyroid

NCT01441154Completed

Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment

Showing all 2 trials

Research Network

Common Treatments

  • 68gallium Dotatate1

Active Sponsors

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2

Top Investigators

Related Conditions

  • Follicular Thyroid Cancer2
  • Papillary Thyroid Cancer2
  • Hurthle Cell Thyroid Cancer2
  • Thyroid Cancer1
  • Malignant Struma Ovarii1

Activity Timeline